Envoy Medical (COCH) Gains from Investment Securities (2021 - 2026)
Envoy Medical's (COCH) quarterly Gains from Investment Securities came in at -$23000.0 in Q2 2026, up 37.84% year-over-year from -$16686.3 in Q2 2025, and down 276.92% quarter-over-quarter from $13000.0 in Q1 2026.
Analysis
Envoy Medical (COCH) Gains from Investment Securities (2021 - 2026) Analysis & Trends
Envoy Medical has disclosed Gains from Investment Securities across 6 years of filings, most recently posting -$23000.0 for Q2 2026.
- In Q2 2026, Gains from Investment Securities rose 37.84% year-over-year to -$23000.0; the TTM figure through Jun 2026 stood at -$86000.0 (up 90.3% YoY), while the FY2025 annual figure was -$534000.0, down 29.93% from the prior year.
- Gains from Investment Securities came in at -$23000.0 for Q2 2026 at Envoy Medical, down from $13000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $311000.0 in Q3 2024 to a low of -$20.0 million in Q4 2022.
- Average Gains from Investment Securities over 5 years is -$2.4 million, with a median of -$162667.0 recorded in 2023.
- Year-over-year, Gains from Investment Securities slumped 2911.97% in 2022 and surged 291.19% in 2024.
- Over 5 years, Gains from Investment Securities stood at -$20.0 million in 2022, then jumped by 94.78% to -$1.0 million in 2023, then rose by 29.25% to -$740000.0 in 2024, then soared by 98.38% to -$12000.0 in 2025, then tumbled by 91.67% to -$23000.0 in 2026.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were -$23000.0 in Q2 2026, $13000.0 in Q1 2026, and -$12000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Envoy Medical | 72.94 Mn | 53.26 Mn | -227,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23,000.00 |
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Jun 30, 2025 | -37,000.00 |
| Mar 31, 2025 | -421,000.00 |
| Dec 31, 2024 | -740,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Jun 30, 2024 | -244,000.00 |
| Mar 31, 2024 | 262,000.00 |
| Dec 31, 2023 | -1.05 Mn |
| Sep 30, 2023 | -162,667.00 |
| Jun 30, 2023 | 266,667.00 |
| Dec 31, 2022 | -20.02 Mn |
| Sep 30, 2022 | -1.33 Mn |
| Jun 30, 2022 | -3.47 Mn |
| Mar 31, 2022 | -14.40 Mn |
| Dec 31, 2021 | 4.00 Mn |
| Sep 30, 2021 | -8.55 Mn |
| Jun 30, 2021 | -1.43 Mn |